-
221
Results of the cicatrization with bevacizumab in the age-related humid macular degeneration
Published 2020-07-01“…Objective: to describe the results of the cicatrization with the use of the bevacizumab in the age-related humid macular degeneration. …”
Get full text
Article -
222
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
Published 2019-02-01Subjects: “…Bevacizumab…”
Get full text
Article -
223
CLINICAL EXPERIENCE OF PROLONGED BEVACIZUMAB THERAPY IN METASTATIC COLORECTAL CANCER
Published 2015-02-01Subjects: Get full text
Article -
224
Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
Published 2007-01-01Get full text
Article -
225
Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
Published 2013-01-01Get full text
Article -
226
Treat-and-extend intravitreal bevacizumab for branch retinal vein occlusion
Published 2014“…BACKGROUND AND OBJECTIVE: To determine the effectiveness and direct medical costs of treat-and-extend (TAE) intravitreal bevacizumab (IVB) for the treatment of branch retinal vein occlusion (BRVO) - associated macular edema (ME). …”
Journal article -
227
Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression.
Published 2016-01-01“…OBJECTIVE:To evaluate the efficacy and safety of pemetrexed, carboplatin and bevacizumab (PCB) followed by maintenance therapy with pemetrexed and bevacizumab (PB) in chemotherapy-naïve patients with stage IV non-squamous non-small cell lung cancer (NSCLC) through the influence of thymidylate synthase (TS) protein and mRNA expression on several outcomes. …”
Get full text
Article -
228
Clinical study on Bevacizumab for macular edema induced by retinal vein occlusion
Published 2014-09-01Subjects: “…bevacizumab…”
Get full text
Article -
229
Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience
Published 2019-04-01Subjects: “…bevacizumab…”
Get full text
Article -
230
Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map
Published 2023-06-01Subjects: “…Bevacizumab…”
Get full text
Article -
231
Periodontal disease in a patient receiving Bevacizumab: a case report
Published 2008-02-01“…Reported side effects due to bevacizumab are hypertension and increased risk of bleeding. …”
Get full text
Article -
232
Atezolizumab plus Bevacizumab as a Bridge for Liver Transplant in Hepatocellular Carcinoma
Published 2023-02-01“…This is a successful report of combined atezolizumab plus bevacizumab being used as a bridge to LT in a patient with HCC, showing an important finding in therapy in patients with unresectable tumors at diagnosis. …”
Get full text
Article -
233
Intravitreal Bevacizumab injection combined duplex technique in treatment of neovascular glaucoma
Published 2015-05-01Subjects: Get full text
Article -
234
Rapid “epiretinal membrane” development following intravitreal bevacizumab for Coats' disease
Published 2018-09-01“…Keywords: Coats disease, Epiretinal membrane, Intravitreal bevacizumab…”
Get full text
Article -
235
Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion
Published 2009-01-01Get full text
Article -
236
Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats
Published 2014-02-01Subjects: Get full text
Article -
237
Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
Published 2011-10-01“…Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.Keywords: retinal vein occlusion, macular edema, bevacizumab…”
Get full text
Article -
238
A Case of Appendiceal Adenocarcinoma with Clinical Benefit from FOLFOX and Bevacizumab
Published 2009-07-01Subjects: Get full text
Article -
239
Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting
Published 2012-07-01“…The mean number of injections per eye was 5.97 with ranibizumab and 5.92 with bevacizumab (P = 0.90).Conclusion: Intravitreal therapies with ranibizumab or bevacizumab have similar visual and anatomical results. …”
Get full text
Article -
240
Use of Bevacizumab for neurological complications during initial treatment of malignant gliomas
Published 2011-01-01“…Keywords: High grade glioma, Radiation necrosis, Tumour progression, Oedema, Corticosteroids, Bevacizumab, Palabras clave: Glioma de alto grado, Radionecrosis, Progresión tumoral, Edema, Corticoides, Bevacizumab…”
Get full text
Article